4/A//SEC Filing
GILL SIMBA 4/A
Accession 0001694665-23-000046
CIK 0001694665other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:11 PM ET
Size
6.0 KB
Accession
0001694665-23-000046
Insider Transaction Report
Form 4/AAmended
GILL SIMBA
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-05-07−23,437→ 351,563 total→ Common Stock (23,437 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001180763
Filing Metadata
- Form type
- 4/A
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:11 PM ET
- Size
- 6.0 KB